EP3823443
Nagdýra-líkön af DITRA-sjúkdómi og notkun á þeim
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
16.7.2019EP published:
22.5.2024EP application number:
19749891.8
EP translation filed:
23.7.2024Grant published:
15.9.2024EPO information:
European Patent Register
Max expiry date:
15.7.2039Expiry date:
15.7.2026Next due date:
31.7.2026
Title in English:
RODENT MODELS OF DITRA DISEASE AND USES THEREOFLanguage of the patent:
English
Timeline
Today
16.7.2019EP application
22.5.2024EP Publication
23.7.2024Translation submitted
15.9.2024Registration published
15.7.2026Expires
Owner
Name:
REGENERON PHARMACEUTICALS, INC.Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707, US
Inventor
Name:
MURPHY, Andrew JAddress:
Tarrytown, New York 10591-6707, US
Name:
MUJICA, Alexander O.Address:
Tarrytown, New York 10591-6707, US
Name:
LAI, Ka-Man VenusAddress:
Seattle, WA 98125, US
Name:
HAXHINASTO, SokolAddress:
Tarrytown, New York 10591-6707, US
Name:
ZARUHI, HovhannisyanAddress:
Tarrytown, New York 10591-6707, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
201862698459 PDate:
16.7.2018Country:
US
Number:
201962867477 PDate:
27.6.2019Country:
US
Classification
Categories:
A01K 67/027, C07K 14/54, C07K 14/715, C12N 15/85
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 24.6.2024
Expires: 15.7.2025
Payer: Árnason Faktor ehf.
Number: 7
Paid: 8.7.2025
Expires: 15.7.2026
Payer: Árnason Faktor ehf.